PAR paradigm biopharmaceuticals limited..

Where are we on a deal?, page-1496

  1. 4,859 Posts.
    lightbulb Created with Sketch. 7546
    Because we are finally moving closer to dosing in a genuine P3 program? One that has been accepted by major multi regions?
    Because we have P3 ready drug that shows both symptomatic and structural relief?
    Because we will soon have a clinical trial that's testing a naturally based compound that isn't stem cell based (hit and miss, potential side effects, expensive) and non addictive?

    Because once approved, the off labelling could be enormous?





    Just saying

    Not advice
    Risks are still there

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
32.5¢
Change
0.035(12.1%)
Mkt cap ! $126.5M
Open High Low Value Volume
29.0¢ 33.5¢ 29.0¢ $692.3K 2.176M

Buyers (Bids)

No. Vol. Price($)
1 11161 32.5¢
 

Sellers (Offers)

Price($) Vol. No.
33.0¢ 134295 1
View Market Depth
Last trade - 16.10pm 24/06/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.